These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 5082465)

  • 21. [Evaluation of the plasma renin activity and urinary aldosterone excretion in patients with essential hypertension treated with spironolactone. Note II].
    Bompiani GD; Scaduto P; Galluzzo A; Donatelli M; Morici ML; Mangano MT; Messina L
    Minerva Cardioangiol; 1976 May; 24(5):352-9. PubMed ID: 1012481
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of renin classification for diuretic treatment of black hypertensive patients.
    Holland OB; Gomez-Sanchez C; Fairchild C; Kaplan NM
    Arch Intern Med; 1979 Dec; 139(12):1365-70. PubMed ID: 518220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of essential hypertension with a combination of propranolol, spironolactone-thiabutazide and dihydralazine (author's transl)].
    Ebel H; Lübke H; Klaus D; Zehner J; Witzgall H
    Dtsch Med Wochenschr; 1978 Oct; 103(42):1650-5. PubMed ID: 699788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A; Mahgoub M; Hall M; Feely J
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison between spironolactone and hydrochlorothiazide with and without alpha-methyldopa in the treatment of hypertension.
    Walter NM; Suthers MB; Friedman A; Johnston CI
    Med J Aust; 1978 May; 1(9):509-12. PubMed ID: 353458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of piretanide on catecholamine metabolism, plasma renin activity and serum aldosterone: a double-blind pilot comparison against hydrochlorothiazide in patients with essential hypertension.
    Verho M; Kirsten R; Bückert C
    Pharmatherapeutica; 1984; 3(9):595-606. PubMed ID: 6374680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The combination of propranolol, hydrochlorothiazide and spironolactone in the treatment of essential arterial hypertension].
    Mauro B; Savagnone E
    Boll Soc Ital Cardiol; 1979; 24(2):189-96. PubMed ID: 548094
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the antihypertensive and hormonal effects of a cardioselective beta-blocker, acebutolol, and diuretics in essential hypertension.
    Alhenc-Gelas F; Plouin PF; Ducrocq MB; Corvol P; Menard J
    Am J Med; 1978 Jun; 64(6):1005-12. PubMed ID: 655186
    [No Abstract]   [Full Text] [Related]  

  • 30. [Spironolactone and thiabutazide in the treatment of essential hypertension (author's transl)].
    Klump F; Braun B; Klaus D; Lemke R; Zehner J; Zöfel P
    Dtsch Med Wochenschr; 1975 Mar; 100(12):577-84. PubMed ID: 1168122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.
    Mahmud A; Feely J
    Am J Hypertens; 2005 Jan; 18(1):50-5. PubMed ID: 15691617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydrochlorothiazide and spironolactone in hypertension.
    Schrijver G; Weinberger MH
    Clin Pharmacol Ther; 1979 Jan; 25(1):33-42. PubMed ID: 363334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of spironolactone in hypertensive patients on regular haemodialysis and after renal allotransplantation.
    Papadimitriou M; Vyzantiadis A; Milionis A; Memmos D; Metaxas P
    Life Support Syst; 1983; 1(3):197-205. PubMed ID: 6433115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged alteration of renin responsiveness after spironolactone therapy. A cause of false-negative testing for low-renin hypertension.
    Lowder SC; Liddle GW
    N Engl J Med; 1974 Dec; 291(23):1243-4. PubMed ID: 4422945
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension].
    Naudzhunas A; Bagdonas G; Yankauskene L; Kazanavichus G
    Ter Arkh; 2006; 78(2):61-4. PubMed ID: 16613101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential response to thiazides and spironolactone in primary aldosteronism.
    Gwinup G; Steinberg T
    Arch Intern Med; 1967 Oct; 120(4):436-43. PubMed ID: 6058098
    [No Abstract]   [Full Text] [Related]  

  • 37. [The effect of alpha methyldopa and spironolactone on angiotensin sensitivity in man].
    Káldor A; Kállay K; Sebestyén K; Alexits K
    Orv Hetil; 1972 Jan; 113(1):23-4. PubMed ID: 4333395
    [No Abstract]   [Full Text] [Related]  

  • 38. [Multi-centric study for the evaluation of the antihypertensive efficacy of hydrochlorothiazide and spironolactone association: comparison between 2 dosages schemes].
    Fariello R; Porcellati C; Innocenti PF; Corea L; Roncati G
    Clin Ter; 1983 Jun; 105(6):477-85. PubMed ID: 6617110
    [No Abstract]   [Full Text] [Related]  

  • 39. [The effect of spironolactone and trichlormethiazide on blood pressure, plasma dry weight and plasma potassium in the elderly hypertension].
    Nakada I; Sekimoto H; Nakano T; Shimada O; Horibe N; Fuse N
    Nihon Ronen Igakkai Zasshi; 1983 Nov; 20(6):491-9. PubMed ID: 6371331
    [No Abstract]   [Full Text] [Related]  

  • 40. [Is essential hypertension still a disease entity? Definition of hyporeninemic hypertension].
    Distler A
    Internist (Berl); 1974 Mar; 15(3):146-54. PubMed ID: 4600300
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.